APA (7th ed.) Citation

R, S. T., HV, M., HJ, H., JT, B., C, d. C., C, B., . . . CU, N. (2024). Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(9), 1959. https://doi.org/10.1158/1078-0432.CCR-23-2522

Chicago Style (17th ed.) Citation

R, Svanberg Teglgaard, et al. "Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 30, no. 9 (2024): 1959. https://doi.org/10.1158/1078-0432.CCR-23-2522.

MLA (9th ed.) Citation

R, Svanberg Teglgaard, et al. "Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 30, no. 9, 2024, p. 1959, https://doi.org/10.1158/1078-0432.CCR-23-2522.